Deconstructing B cell tolerance to basement membranes

Archivum Immunologiae et Therapiae Experimentalis

Volumn 54, Issue 4, 2006, Pages 227-237

  Foster, Mary H ^a,b   Zhang, Ying ^a   Clark, Amy G ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autoantibody; B cell tolerance; Basement membrane; Laminin

Indexed keywords

EPITOPE; IMMUNOGLOBULIN; IMMUNOGLOBULIN KAPPA CHAIN; LAMININ;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BASEMENT MEMBRANE; CLONAL ANERGY; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; NONHUMAN; REVIEW; TRANSGENE;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; BASEMENT MEMBRANE; COLLAGEN TYPE IV; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LAMININ; MICE; MICE, TRANSGENIC; SELF TOLERANCE;

EID: 33747185672     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-006-0027-x     Document Type: Review

References (90)

1. Abrahamson D. R. and Caulfield J. P. (1982): Proteinuria and structural alterations in rat glomerular basement membranes induced by intravenously injected anti-laminin immunoglobulin G. J. Exp. Med., 156, 128-145.
2. Abrahamson D. R., Prettyman A. C., Robert B. and St John P. L. (2003): Laminin-1 reexpression in alport mouse glomerular basement membranes. Kidney Int., 63, 826-834.
3. Adelstein S., Pritchard-Briscoe H., Anderson T. A., Crosbie J., Gammon G., Loblay R. H., Basten A. and Goodnow C. C. (1991): Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science, 251, 1223-1225.
4. Akkaraju S., Canaan K. and Goodnow C. C. (1997): Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells. J. Exp. Med., 186, 2005-2012.
5. Amital H., Heilweil M., Ulmansky R., Szafer F., Bar-Tana R., Morel L., Foster M. H., Mostoslavsky G., Eilat D., Pizov G. and Naparstek Y. (2005): Treatment with a laminin-derived peptide suppresses lupus nephritis. J. Immunol., 175, 5516-5523.
6. Aplin B. D., Keech C. L., de Kauwe A. L., Gordon T. P., Cavill D. and McCluskey J. (2003): Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model. J. Immunol., 171, 5890-5900.
7. Aumailley M., Bruckner-Tuderman L., Carter W. G., Deutzmann R., Edgar D., Ekblom P., Engel J., Engvall E., Hohenester E., Jones J. C., Kleinman H. K., Marinkovich M. P., Martin G. R., Mayer U., Meneguzzi G., Miner J. H., Miyazaki K., Patarroyo M., Paulsson M., Quaranta V., Sanes J. R., Sasaki T., Sekiguchi K., Sorokin L. M., Talts J. F., Tryggvason K., Uitto J., Virtanen I., von der Mark K., Wewer U. M., Yamada Y. and Yurchenco P. D. (2005): A simplified laminin nomenclature. Matrix Biol., 24, 326-332.
8. Ben-Yehuda A., Rasooly L., Bar-Tana R., Breuer G., Tadmor B., Ulmansky R. and Naparstek Y. (1995): The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J. Autoimmun., 8, 279-291.
9. Borza D. B., Netzer K. O., Leinonen A., Todd P., Cervera J., Saus J. and Hudson B. G. (2000): The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J. Biol. Chem., 275, 6030-6037.
10. Brady G. F., Congdon K. L., Clark A. G., Sackey F. N., Rudolph E. H., Radic M. Z. and Foster M. H. (2004): Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig. J. Immunol., 172, 5313-5321.
11. Brainwood D., Kashtan C., Gubler M. C. and Turner A. N. (1998): Targets of alloantibodies in alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int., 53, 762-766.
12. Bruijn J. A., Hogendoorn P. C., Corver W. E., Van den Broek L. J., Hoedemaeker P. J. and Fleuren G. J. (1990): Pathogenesis of experimental lupus nephritis: A role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin. Exp. Immunol., 79, 115-122.
13. Bruijn J. A., van Leer E. H., Baelde H. J., Corver W. E., Hogendoorn P. C. and Fleuren G. J. (1990): Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis. Lab. Invest., 63, 350-359.
14. Carmack C., Camper S., Mackle J., Gerhard W. and Weigert M. (1991): Influence of a V kappa 8 L chain transgene on endogenous rearrangements and the immune response to the HA(Sb) determinant on influenza virus. J. Immunol., 15, 2024-2033.
15. Chen C., Radic M. Z., Erikson J., Camper S. A., Litwin S., Hardy R. R. and Weigert M. (1994): Deletion and editing of B cells that express antibodies to DNA. J. Immunol., 152, 1970-1982.
16. Chen C., Nagy Z., Prak E. L. and Weigert M. (1995): Immunoglobulin heavy chain gene replacement: A mechanism of receptor editing. Immunity, 3, 747-755.
17. Chen C., Prak E. L. and Weigert M. (1997): Editing disease-associated autoantibodies. Immunity, 6, 97-105.
18. Clayman M., Michaud L., Brentjens J., Andres G., Kefalides N. and Neilson E. (1986): Isolation of the target antigen of human anti-tubular basement membrane antibody-associated interstitial nephritis. J. Clin. Invest., 77, 1143-1147.
19. Colognato H. and Yurchenco P. (2000): Form and function: The laminin family of heterotrimers. Dev. Dyn., 218, 213-234.
20. Erikson J., Radic M. Z., Camper S. A., Hardy R. R., Carmack C. and Weigert M. (1991): Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature, 349, 331-334.
21. Falk M., Ferletta M., Forsberg E. and Ekblom P. (1999): Restricted distribution of laminin alpha1 chain in normal adult mouse tissues. Matrix Biol., 18, 557-568.
22. Feintzeig I. D., Abrahamson D. R., Cybulsky A. V., Dittmer J. E. and Salant D. J. (1986): Nephritogenic potential of sheep antibodies against glomerular basement membrane laminin in the rat. Lab. Invest., 54, 531-542.
23. Ferry H., Jones M., Vaux D. J., Roberts I. S. and Cornall R. J. (2003): The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J. Exp. Med., 198, 1415-1425.
24. Fitzsimons M. M., Chen H. and Foster M. H. (2000): Diverse endogenous light chains contribute to basement membrane reactivity in nonautoimmune mice transgenic for an anti-laminin Ig heavy chain. Immunogenetics, 51, 20-29.
25. Florquin S., Abramowicz D., de Heer E., Bruijn J. A., Doutrelepont J. M., Goldman M. and Hoedemaeker P. (1991): Renal immunopathology in murine host-versus-graft disease. Kidney Int., 40, 852-861.
26. Fossati L., Sobel E. S., Iwamoto M., Cohen P. L., Eisenberg R. A. and Izui S. (1995): The Yaa gene-mediated acceleration of murine lupus: Yaa- T cells from non-autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo. Eur. J. Immunol., 25, 3412-3417.
27. Foster M. H., Liu Q., Chen H., Nemazee D. and Cooperstone B. (1997): Anti-laminin reactivity and glomerular immune deposition by in vitro recombinant antibodies. Autiommunity, 26, 231-243.
28. Foster M. H., Sabbaga J., Line S. R., Thompson K. S., Barrett K. J. and Madaio M. P. (1993): Molecular analysis of spontaneous nephrotropic anti-laminin antibodies in an autoimmune MRL-lpr/lpr mouse. J. Immunol., 151, 814-824.
29. Foster M. H. and Fitzsimons M. M. (1998): Lupus-like nephrotropic autoantibodies in nonautoimmune mice harboring an anti-laminin Ig heavy chain transgene. Mol. Immunol., 35, 83-94.
30. Gammon W. R. and Briggaman R. A. (1993): Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol. Clin., 11, 535-547.
31. Gay D., Saunders T., Camper S. and Weigert M. (1993): Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med., 177, 999-1008.
32. Ghohestani R., Hudson B., Claudy A. and Uitto J. (2000): The alpha 5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency. J. Biol. Chem., 275, 16002-16006.
33. Goodnow C. (1997): Balancing immunity, autoimmunity, and self-tolerance. Ann. NY Acad. Sci., 815, 55-66.
34. Goodnow C. C., Crosbie J., Adelstein S., Lavoie T. B., Smith-Gill S.J., Brink R. A., Pritchard-Briscoe H., Wotherspoon J. S., Loblay R. H., Raphael K., Trent R. J. and Basten A. (1988): Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature, 334, 676-682.
35. Gu Y., Sorokin L., Durbeej M., Hjalt T., Jonsson J. I. and Ekblom M. (1999): Characterization of bone marrow laminins and identification of alpha5-containing laminins as adhesive proteins for multipotent hematopoietic FDCP-Mix cells. Blood, 93, 2533-2542.
36. Guery J. C., Druet E., Glotz D., Hirsch F., Mandet C., De Heer E. and Druet P. (1990): Specificity and cross-reactive idiotypes of anti-glomerular basement membrane autoantibodies in HgCl2-induced autoimmune glomerulonephritis. Eur. J. Immunol., 20, 93-100.
37. Hannum L., Ni D., Haberman A., Weigert M. and Shlomchik M. (1996): A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J. Exp. Med., 184, 1269-1278.
38. Haque M. A., Mizobuchi T., Yasufuku K., Fujisawa T., Brutkiewicz R. R., Zheng Y., Woods K., Smith G. N., Cummings O. W., Heidler K. M., Blum J. S. and Wilkes D. S. (2002): Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J. Immunol., 169, 1542-1549.
39. Hartley S. B., Crosbie J., Brink R., Kantor A. B., Basten A. and Goodnow C. C. (1991): Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature, 353, 765-769.
40. Haywood M. E., Vyse T. J., McDermott A., Thompson E. M., Ida A., Walport M. J., Izui S. and Morley B. J. (2001): Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone BXSB mice. J. Immunol., 167, 1728-1733.
41. Hecox D. B. and Foster M. H. (2004): Recent research developments in immunology: regulation of humoral autoimmunity to basement membrane antigens. Research Signposts: Recent Res. Dev. Immunol., 6, 95-121.
42. Izui S., Ibnou-Zekri N., Fossati-Jimack L. and Iwamoto M. (2000): Lessons from BXSB and related mouse models. Int. Rev. Immunol., 19, 447-472.
43. Kalluri R., Cantley L., Kerjaschki D. and Neilson E. (2000): Reactive oxygen species expose cryptic epitopes associated with autoimmune goodpasture syndrome. J. Biol. Chem, 275, 20027-20032.
44. Karp S. L., Kieber-Emmons T., Sun M. J., Wolf G. and Neilson E. G. (1993): Molecular structure of a cross-reactive idiotype on autoantibodies recognizing parenchymal self. J. Immunol., 150, 867-879.
45. Kefalides N., Pegg M., Ohno N., Poon-King T., Zabriske J. and Fillit H. (1986): Antibodies to basement membrane collagen and to laminin are present in sera from patients with post-streptococcal glomerulonephritis. J. Exp. Med., 163, 588-602.
46. Kelley V. E. and Roths J. B. (1985): Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol., 37, 220-229.
47. Kirtschig G., Marinkovich M. P., Burgeson R. E. and Yancey K. B. (1995): Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J. Invest. Dermatol., 105, 543-548.
48. Kootstra C. J., Bergijk E. C., Veninga A., Prins F. A., Heer E. D., Abrahamsom D. R. and Bruijn J. A. (1995): Qualitative alterations in laminin expression in experimental lupus nephritis. Am. J. Pathol., 147, 476-488.
49. Kouskoff V., Lacaud G. and Nemazee D. (2000): T cell-independent rescue of B lymphocytes from peripheral immune tolerance. Science, 287, 2501-2503.
50. Kouskoff V., Lacaud G., Pape K., Retter M. and Nemazee D. (2000): B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection. Proc. Natl. Acad. Sci. USA, 97, 7435-7439.
51. Lang J., Jackson M., Teyton L., Brunmark A., Kane K. and Nemazee D. (1996): B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J. Exp. Med., 184, 1685-1697.
52. Lazarova Z., Yee C., Darling T., Briggaman R. A. and Yancey K. B. (1996): Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J. Clin. Invest., 98, 1509-1518.
53. Litzenburger T., Fassler R., Bauer J., Lassmann H., Linington C., Wekerle H. and Iglesias A. (1998): B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med., 188, 169-180.
54. Luross J. A. and Williams N. A. (2001): The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology, 103, 407-416.
55. Maibaum M. A., Haywood M. E., Walport M. J. and Morley B. J. (2000): Lupus susceptibility loci map within regions of BXSB derived from the SB/Le parental strain. Immunogenetics, 51, 370-372.
56. Mandik-Nayak L., Seo S., Sokol C., Potts K., Bui A. and Erikson J. (1999): MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med., 189, 1799-1814.
57. Melamed D. and Nemazee D. (1997): Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc. Natl. Acad. Sci. USA, 94, 9267-9272.
58. Merino R., Fossati L., Lacour M. and Izui S. (1991): Selective autoantibody production by Yaa+ B cells in autoimmune Yaa+-Yaa- bone marrow chimeric mice. J. Exp. Med., 174, 1023-1029.
59. Moll R. and Moll I. (1998): Epidermal adhesion molecules and basement membrane components as target structures of autoimmunity. Virchows Arch., 432, 487-504.
60. Moser K. L., Gaffney P., Peterson E. and Behrens T. (2004): Keys to unlocking the mysteries of rheumatic autoimmune disease. Minn. Med., 87, 46-51.
61. Murphy-Ullrich J. E. and Oberley T. D. (1984): Immune-mediated injury to basement membranes in mice immunized with murine laminin. Clin. Immunol. Immunopathol., 31, 33-43.
62. Myllyharju J. and Kivirikko K. I. (2001): Collagens and collagen-related diseases. Ann. Med., 33, 7-21.
63. Nelson T., Charonis A., McIvor R. and Butkowski R. (1995): Identification of a cDNA encoding tubulointerstitial nephritis antigen. J. Biol. Chem., 270, 16265-16270.
64. Nemazee D. (1996): Antigen receptor "capacity" and the sensitivity of self-tolerance. Immunol. Today, 17, 25-29.
65. Nemazee D. (2000): Receptor selection in B and T lymphocytes. Annu. Rev. Immunol., 18, 19-51.
66. Nemazee D. A. and Burki K. (1989): Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature, 337, 562-566.
67. Nossal G. J. (2001): A purgative mastery. Nature, 412, 685-686.
68. Okamoto M., Murakami M., Shimizu A., Ozaki S., Tsubata T., Kumagai S. and Honjo T. (1992): A transgenic model of autoimmune hemolytic anemia. J. Exp. Med., 175, 71-79.
69. Paulson M. (1992): Basement membrane proteins: Structure, assembly, and cellular interactions. Crit. Rev. Biochem. Molec. Biol., 27, 93-127.
70. Pelanda R., Schwers S., Sonoda E., Torres R. M., Nemazee D. and Rajewsky K. (1997): Receptor editing in a transgenic mouse model: Site, efficiency, and role in B cell tolerance and antibody diversification. Immunity, 7, 765-775.
71. Prak E. L., Trounstine M., Huszar D. and Weigert M. (1994): Light chain editing in kappa-deficient animals: A potential mechanism of B cell tolerance. J. Exp. Med., 180, 1805-1815.
72. Prak E. L. and Weigert M. (1995): Light chain replacement: a new model for antibody gene rearrangement. J. Exp. Med., 182, 541-548.
73. Radic M. Z., Erikson J., Litwin S. and Weigert M. (1993): B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med., 177, 1165-1173.
74. Rudolph E. H., Congdon K. L., Sackey F. N., Fitzsimons M. M. and Foster M. H. (2002): Humoral autoimmunity to basement membrane antigens is regulated in c57bl/6 and MRL/mpj mice transgenic for anti-laminin Ig receptors. J. Immunol., 168, 5943-5953.
75. Sabbaga J., Line S. R., Potocnjak P. and Madaio M. P. (1989): A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur. J. Immunol., 19, 137-143.
76. Santulli-Marotto S., Qian Y., Ferguson S. and Clarke S. H. (2001): Anti-Sm B cell differentiation in Ig transgenic MRL/mp-lpr/lpr mice: altered differentiation and an accelerated response. J. Immunol., 166, 5292-5299.
77. Saus J., Wieslander J., Langeveld J., Quinones S. and Hudson B. (1988): Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J. Biol. Chem., 263, 13374-13380.
78. Schulte S., Unger C., Mo J. A., Wendler O., Bauer E., Frischholz S., von der Mark K., Kalden J. R., Holmdahl R. and Burkhardt H. (1998): Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J. Biol. Chem., 273, 1551-1561.
79. Termaat R. M., Assmann K. J., van Son J. P., Dijkman H. B.., Koene R. A. and Berden J. H. (1993): Antigen-specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus-like syndromes. Lab. Invest., 68, 164-173.
80. Theofilopoulos A. N. and Dixon F. J. (1985): Murine models of systemic lupus erythematosus. Adv. Immunol., 37, 269-390.
81. Tiegs S. L., Russell D. M. and Nemazee D. (1993): Receptor editing in self-reactive bone marrow B cells. J. Exp. Med., 177, 1009-1020.
82. Tze L. E., Baness E. A., Hippen K. L. and Behrens T. W. (2000): Ig light chain receptor editing in anergic B cells. J. Immunol., 165, 6796-6802.
83. Vidal S., Kono D. H. and Theofilopoulos A. N. (1998): Loci predisposing to autoimmunity in MRL-Fas lpr and C57Bl/6-Faslpr mice. J. Clin. Invest., 101, 696-702.
84. Wang H. and Shlomchik M. J. (1997): High affinity rheumatoid factor transgenic B cells are eliminated in normal mice. J. Immunol., 159, 1125-1134.
85. Wang X. P., Fogo A. B., Colon S., Giannico G., Abul-Ezz S. R., Miner J. H. and Borza D. B. (2005): Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: A janus-faced antigen. J. Am. Soc. Nephrol., 16, 3563-3571.
86. Wardemann H., Yurasov S., Schaefer A., Young J. W., Meffre E. and Nussenzweig M. C. (2003): Predominant autoantibody production by early human B cell precursors. Science, 301, 1374-1377.
87. Watson M. L., Rao J. K., Gilkeson G. S., Ruiz P., Eicher E. M., Pisetsky D. S., Matsuzawa A., Rochelle J. M. and Seldin M. F. (1992): Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med., 176, 1645-1656.
88. Wieslander J., Barr J. F., Butkowski R. J., Edwards S. J., Bygren P., Heinegard D. and Hudson B. G. (1984): Good-pasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen. Proc. Natl. Acad. Sci. USA, 81, 3838-3842.
89. Xu L., Robinson N., Miller S. D. and Chan L. S. (2001): Characterization of BALB/c mice B lymphocyte autoimmune responses to skin basement membrane component type XVII collagen, the target antigen of autoimmune skin disease bullous pemphigoid. Immunol. Lett., 77, 105-111.
90. Yoshida T., Higuchi T., Hagiyama H., Strasser A., Nishioka K. and Tsubata T. (2000): Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or Crma-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice. Int. Immunol., 12, 517-526.